Logo image of ALT

ALTIMMUNE INC (ALT) Stock Fundamental Analysis

USA - NASDAQ:ALT - US02155H2004 - Common Stock

4 USD
-0.06 (-1.48%)
Last: 10/29/2025, 7:13:24 PM
3.9738 USD
-0.03 (-0.65%)
After Hours: 10/29/2025, 7:13:24 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ALT. ALT was compared to 534 industry peers in the Biotechnology industry. ALT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALT has reported negative net income.
In the past year ALT has reported a negative cash flow from operations.
In the past 5 years ALT always reported negative net income.
ALT had a negative operating cash flow in each of the past 5 years.
ALT Yearly Net Income VS EBIT VS OCF VS FCFALT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

ALT has a Return On Assets of -46.10%. This is comparable to the rest of the industry: ALT outperforms 53.75% of its industry peers.
ALT has a better Return On Equity (-54.38%) than 64.61% of its industry peers.
Industry RankSector Rank
ROA -46.1%
ROE -54.38%
ROIC N/A
ROA(3y)-50.39%
ROA(5y)-43.11%
ROE(3y)-56.08%
ROE(5y)-47.74%
ROIC(3y)N/A
ROIC(5y)N/A
ALT Yearly ROA, ROE, ROICALT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ALT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALT Yearly Profit, Operating, Gross MarginsALT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200K -400K

More info and screens

5

2. Health

2.1 Basic Checks

ALT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALT has more shares outstanding
The number of shares outstanding for ALT has been increased compared to 5 years ago.
ALT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ALT Yearly Shares OutstandingALT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ALT Yearly Total Debt VS Total AssetsALT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 2.48 indicates that ALT is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.48, ALT is in the better half of the industry, outperforming 66.85% of the companies in the same industry.
ALT has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.09, ALT is doing worse than 63.11% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Altman-Z 2.48
ROIC/WACCN/A
WACC8.63%
ALT Yearly LT Debt VS Equity VS FCFALT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

A Current Ratio of 20.44 indicates that ALT has no problem at all paying its short term obligations.
ALT has a better Current ratio (20.44) than 94.57% of its industry peers.
A Quick Ratio of 20.44 indicates that ALT has no problem at all paying its short term obligations.
ALT has a better Quick ratio (20.44) than 94.57% of its industry peers.
Industry RankSector Rank
Current Ratio 20.44
Quick Ratio 20.44
ALT Yearly Current Assets VS Current LiabilitesALT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.31% over the past year.
ALT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -95.09%.
The Revenue for ALT have been decreasing by -67.82% on average. This is quite bad
EPS 1Y (TTM)16.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.86%
Revenue 1Y (TTM)-95.09%
Revenue growth 3Y-83.45%
Revenue growth 5Y-67.82%
Sales Q2Q%0%

3.2 Future

Based on estimates for the next years, ALT will show a very strong growth in Earnings Per Share. The EPS will grow by 39.39% on average per year.
ALT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 889.71% yearly.
EPS Next Y16.26%
EPS Next 2Y-0.21%
EPS Next 3Y6%
EPS Next 5Y39.39%
Revenue Next Year37.6%
Revenue Next 2Y-24.37%
Revenue Next 3Y1667.5%
Revenue Next 5Y889.71%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALT Yearly Revenue VS EstimatesALT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 500M 1B 1.5B
ALT Yearly EPS VS EstimatesALT Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 20 -20 -40 -60 -80

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALT Price Earnings VS Forward Price EarningsALT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALT Per share dataALT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.21%
EPS Next 3Y6%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALTIMMUNE INC

NASDAQ:ALT (10/29/2025, 7:13:24 PM)

After market: 3.9738 -0.03 (-0.65%)

4

-0.06 (-1.48%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-12 2025-08-12/bmo
Earnings (Next)11-11 2025-11-11/bmo
Inst Owners43.36%
Inst Owner Change-0.37%
Ins Owners0.77%
Ins Owner Change0.08%
Market Cap353.04M
Revenue(TTM)20.00K
Net Income(TTM)-87746000
Analysts78.57
Price Target18.81 (370.25%)
Short Float %24.56%
Short Ratio7.91
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.17%
Min EPS beat(2)17.24%
Max EPS beat(2)29.11%
EPS beat(4)4
Avg EPS beat(4)14.25%
Min EPS beat(4)0.21%
Max EPS beat(4)29.11%
EPS beat(8)7
Avg EPS beat(8)12.17%
EPS beat(12)11
Avg EPS beat(12)13.97%
EPS beat(16)14
Avg EPS beat(16)7.16%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2.35%
EPS NQ rev (1m)0.97%
EPS NQ rev (3m)20.27%
EPS NY rev (1m)0.44%
EPS NY rev (3m)15.68%
Revenue NQ rev (1m)98.41%
Revenue NQ rev (3m)76.06%
Revenue NY rev (1m)23.74%
Revenue NY rev (3m)22.2%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 17652
P/FCF N/A
P/OCF N/A
P/B 2.19
P/tB 2.19
EV/EBITDA N/A
EPS(TTM)-1.18
EYN/A
EPS(NY)-1.35
Fwd EYN/A
FCF(TTM)-0.92
FCFYN/A
OCF(TTM)-0.92
OCFYN/A
SpS0
BVpS1.83
TBVpS1.83
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -46.1%
ROE -54.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-50.39%
ROA(5y)-43.11%
ROE(3y)-56.08%
ROE(5y)-47.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 20.44
Quick Ratio 20.44
Altman-Z 2.48
F-Score3
WACC8.63%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.86%
EPS Next Y16.26%
EPS Next 2Y-0.21%
EPS Next 3Y6%
EPS Next 5Y39.39%
Revenue 1Y (TTM)-95.09%
Revenue growth 3Y-83.45%
Revenue growth 5Y-67.82%
Sales Q2Q%0%
Revenue Next Year37.6%
Revenue Next 2Y-24.37%
Revenue Next 3Y1667.5%
Revenue Next 5Y889.71%
EBIT growth 1Y2.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3.71%
EBIT Next 3Y-16.88%
EBIT Next 5Y13.54%
FCF growth 1Y-14.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-14.65%
OCF growth 3YN/A
OCF growth 5YN/A

ALTIMMUNE INC / ALT FAQ

What is the ChartMill fundamental rating of ALTIMMUNE INC (ALT) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALT.


Can you provide the valuation status for ALTIMMUNE INC?

ChartMill assigns a valuation rating of 0 / 10 to ALTIMMUNE INC (ALT). This can be considered as Overvalued.


Can you provide the profitability details for ALTIMMUNE INC?

ALTIMMUNE INC (ALT) has a profitability rating of 1 / 10.


Can you provide the financial health for ALT stock?

The financial health rating of ALTIMMUNE INC (ALT) is 5 / 10.


What is the earnings growth outlook for ALTIMMUNE INC?

The Earnings per Share (EPS) of ALTIMMUNE INC (ALT) is expected to grow by 16.26% in the next year.